Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-09 · accession 0001883850-22-000122 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-13 | 2022-12-09 | REGN | LAROSA JOSEPH J | EVP GC, Secret | F - Tax | $753.28 | -492 | 20.4K | -2% | -$370.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-09 | F | D | 492 | $753.28 | 20,358 | D | — | — |